| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1006/EXNR.1996.6396 |
| P698 | PubMed publication ID | 9126160 |
| P2093 | author name string | Li J | |
| Samulski RJ | |||
| Xiao X | |||
| McCown TJ | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vector-borne disease | Q2083837 |
| P304 | page(s) | 113-124 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Experimental Neurology | Q5421127 |
| P1476 | title | Gene transfer by adeno-associated virus vectors into the central nervous system | |
| P478 | volume | 144 |
| Q92856615 | A New Projection From the Deep Cerebellar Nuclei to the Hippocampus via the Ventrolateral and Laterodorsal Thalamus in Mice |
| Q36242844 | A Single Vector Platform for High-Level Gene Transduction of Central Neurons: Adeno-Associated Virus Vector Equipped with the Tet-Off System |
| Q33799084 | A chimeric protein containing the N terminus of the adeno-associated virus Rep protein recognizes its target site in an in vivo assay |
| Q45752547 | A neuron-specific gene transfer by a recombinant defective Sindbis virus |
| Q39893541 | AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice |
| Q37260178 | AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice |
| Q45884480 | Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma |
| Q30885494 | Adeno-associated viral vectors and their redirection to cell-type specific receptors |
| Q48586865 | Adeno-associated viral vectors for anterograde axonal tracing with fluorescent proteins in nontransgenic and cre driver mice |
| Q35216648 | Adeno-associated viral vectors. |
| Q40994121 | Adeno-associated virus expression systems for gene transfer |
| Q34063628 | Adeno-associated virus serotypes 1, 8, and 9 share conserved mechanisms for anterograde and retrograde axonal transport. |
| Q45728411 | Adeno-associated virus vector expressing nerve growth factor enhances cholinergic axonal sprouting after cortical injury in rats. |
| Q45740016 | Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous system |
| Q45457280 | Adeno-associated virus-mediated gene transfer to hair cells and support cells of the murine cochlea |
| Q28141743 | Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q34953198 | Alphaviral gene transfer in neurobiology |
| Q47230840 | Cloning of a novel Apaf-1-interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death. |
| Q33296224 | Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer |
| Q33645324 | Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model |
| Q24797018 | Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors |
| Q33713355 | Efficient intrathymic gene transfer following in situ administration of a rAAV serotype 8 vector in mice and nonhuman primates. |
| Q40321040 | Endostatin therapy reveals a U-shaped curve for antitumor activity |
| Q45882831 | Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models. |
| Q34997245 | Enhancement of Recombinant Adeno-Associated Virus Type 2-Mediated Transgene Expression in a Lung Epithelial Cell Line by Inhibition of the Epidermal Growth Factor Receptor |
| Q46386515 | Extracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo |
| Q35621081 | FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders |
| Q44686144 | Fibroblast growth factor-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury |
| Q33997202 | Formation of AAV single stranded DNA genome from a circular plasmid in Saccharomyces cerevisiae |
| Q33793572 | Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy |
| Q45856156 | Gene therapy for inherited neurological disorders: towards therapeutic intervention in the Lesch-Nyhan syndrome. |
| Q30357745 | Gene therapy for metachromatic leukodystrophy. |
| Q64381800 | Gene therapy for rheumatoid arthritis |
| Q36786243 | Gene therapy in the treatment of heart failure |
| Q33534302 | Gene transfer to the brain: emerging therapeutic strategy in psychiatry? |
| Q37305249 | Gene transfer using bovine adeno-associated virus in the guinea pig cochlea |
| Q35131227 | Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy |
| Q45869654 | Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain |
| Q41884818 | Influences of HIF-lα on Bax/Bcl-2 and VEGF expressions in rats with spinal cord injury |
| Q34126428 | Inhibitory RNA in epilepsy: research tools and therapeutic perspectives |
| Q34992549 | Insight into the mechanism of inhibition of adeno-associated virus by the Mre11/Rad50/Nbs1 complex |
| Q37413701 | Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD mice |
| Q41713142 | Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain. |
| Q34128898 | Intrathecal delivery of a mutant micro-opioid receptor activated by naloxone as a possible antinociceptive paradigm. |
| Q33870310 | Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome. |
| Q37265519 | Large animal models of neurological disorders for gene therapy |
| Q24527302 | Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model |
| Q37378737 | Local knockdown of ERK2 in the adult mouse brain via adeno-associated virus-mediated RNA interference. |
| Q30573520 | Long-distance axonal transport of AAV9 is driven by dynein and kinesin-2 and is trafficked in a highly motile Rab7-positive compartment |
| Q33221962 | Long-term safety of GDNF gene delivery in the retina |
| Q28766660 | Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells |
| Q35565452 | Molecular basis of Canavan's disease: from human to mouse |
| Q41634721 | New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors |
| Q45743733 | Oligodendrocyte-specific gene expression in mouse brain: use of a myelin-forming cell type-specific promoter in an adeno-associated virus |
| Q33824969 | Overexpression of cyclin A inhibits augmentation of recombinant adeno-associated virus transduction by the adenovirus E4orf6 protein |
| Q33753300 | Phosphatidylserine immobilization of lentivirus for localized gene transfer |
| Q24523073 | Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus |
| Q34987192 | Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain |
| Q46383994 | Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo. |
| Q45735544 | Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. |
| Q45007196 | Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system |
| Q91707074 | Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here? |
| Q36390517 | Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures |
| Q45411417 | Recombinant adeno-associated virus preferentially transduces human, compared to mouse, synovium: implications for arthritis therapy |
| Q31139438 | Recombinant adeno-associated virus vector expressing angiostatin inhibits preretinal neovascularization in adult rats |
| Q34472181 | Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS |
| Q33823405 | Repeated delivery of adeno-associated virus vectors to the rabbit airway |
| Q45868070 | Ribozyme gene therapy for autosomal dominant retinal disease. |
| Q34058780 | Ribozyme uses in retinal gene therapy. |
| Q42012887 | Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system |
| Q42007195 | Stereotaxic microinjection of viral vectors expressing Cre recombinase to study the role of target genes in cocaine conditioned place preference |
| Q27681034 | Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20 |
| Q37295510 | Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist |
| Q45236560 | Systemic mannitol-induced hyperosmolality amplifies rAAV2-mediated striatal transduction to a greater extent than local co-infusion |
| Q30411312 | Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. |
| Q35136635 | Targeting neurons of rat nucleus tractus solitarii with the gene transfer vector adeno-associated virus type 2 to up-regulate neuronal nitric oxide synthase |
| Q36337994 | The assessment of adeno-associated vectors as potential intrinsic treatments for brainstem axon regeneration |
| Q45420843 | Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain |
| Q45884333 | Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors |
| Q34399110 | Treatment of GM2 gangliosidosis: past experiences, implications, and future prospects |
| Q43999162 | TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. |
| Q36541150 | Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro. |
| Q33747865 | Two-photon imaging of calcium in virally transfected striate cortical neurons of behaving monkey |
| Q36370376 | Use of Adeno-Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice |
| Q41909454 | Use of self-complementary adeno-associated virus serotype 2 as a tracer for labeling axons: implications for axon regeneration |
| Q58119543 | Viral-vectored ribozymes as therapy for autosomal dominant retinal disease |
| Q39611260 | Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector |
Search more.